Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma

SIMPLE SUMMARY: Trabectedin is a cytotoxic drug used for the treatment of advanced soft tissue sarcoma. One of the most frequent side effects is hepatotoxicity, which occurs in nearly 40% of patients. In this pharmacogenetic study, we aimed to identify genetic polymorphisms that could impair the fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Maillard, Maud, Chevreau, Christine, Le Louedec, Félicien, Cassou, Manon, Delmas, Caroline, Gourdain, Laure, Blay, Jean-Yves, Cupissol, Didier, Bompas, Emmanuelle, Italiano, Antoine, Isambert, Nicolas, Delcambre-Lair, Corinne, Penel, Nicolas, Bertucci, François, Guillemet, Cécile, Plenecassagnes, Julien, Foulon, Stéphanie, Chatelut, Étienne, Le Cesne, Axel, Thomas, Fabienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761985/
https://www.ncbi.nlm.nih.gov/pubmed/33291741
http://dx.doi.org/10.3390/cancers12123647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761985/
https://www.ncbi.nlm.nih.gov/pubmed/33291741
http://dx.doi.org/10.3390/cancers12123647

Ejemplares similares